Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Apple
AAPL
|
+$1.01B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$764M |
| 4 |
Broadcom
AVGO
|
+$712M |
| 5 |
Microsoft
MSFT
|
+$647M |
Top Sells
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.19B |
| 2 |
Tesla
TSLA
|
+$871M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$698M |
| 4 |
Micron Technology
MU
|
+$498M |
| 5 |
Strategy Inc Common Stock Class A
MSTR
|
+$492M |
Sector Composition
| 1 | Technology | 19.55% |
| 2 | Financials | 8.86% |
| 3 | Consumer Discretionary | 8.18% |
| 4 | Healthcare | 7.45% |
| 5 | Communication Services | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5726
Empire Petroleum
EP
$137M
| $89.3K | ﹤0.01% |
+11,756
| New | +$89.3K |
|
5727
Heron Therapeutics
HRTX
$193M
| $89.2K | ﹤0.01% |
58,311
-68,806
| -54% | -$105K |
|
5728
Telos
TLS
$490M
| $88.2K | ﹤0.01% |
25,797
-21,169
| -45% | -$72.4K |
|
5729
Gores Guggenheim
PSNY
$2B
| $87.6K | ﹤0.01% |
83,433
-683,597
| -89% | -$718K |
|
5730
Ultralife
ULBI
$114M
| $87.6K | ﹤0.01% |
11,758
-17,443
| -60% | -$130K |
|
|
GF
5731
New Germany Fund
GF
$186M
| $87.5K | ﹤0.01% |
11,215
-1,523
| -12% | -$11.9K |
|
5732
Fractyl Health
GUTS
$72.2M
| $87.3K | ﹤0.01% |
+42,374
| New | +$87.3K |
|
5733
Nuveen Preferred & Income Opportunities Fund
JPC
$2.66B
| $86.8K | ﹤0.01% |
+11,042
| New | +$86.8K |
|
5734
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.76B
| $86.1K | ﹤0.01% |
+10,533
| New | +$86.1K |
|
|
FGB
5735
DELISTED
First Trust Specialty Finance and Financial Opportunities Fund
FGB
| $85.7K | ﹤0.01% |
20,347
-6,142
| -23% | -$25.9K |
|
5736
OPAL Fuels
OPAL
$61.5M
| $85.5K | ﹤0.01% |
25,219
+7,618
| +43% | +$25.8K |
|
5737
Perspective Therapeutics
CATX
$258M
| $84.3K | ﹤0.01% |
26,439
+5,853
| +28% | +$18.7K |
|
5738
ProKidney
PROK
$335M
| $84.2K | ﹤0.01% |
+49,794
| New | +$84.2K |
|
|
NFGC
5739
New Found Gold
NFGC
$508M
| $83.9K | ﹤0.01% |
+46,101
| New | +$83.9K |
|
5740
Lantern Pharma
LTRN
$41.4M
| $83.9K | ﹤0.01% |
26,301
+4,420
| +20% | +$14.1K |
|
|
ZTR
5741
Virtus Total Return Fund
ZTR
$349M
| $83.9K | ﹤0.01% |
+14,310
| New | +$83.9K |
|
5742
Purple Innovation
PRPL
$114M
| $83.8K | ﹤0.01% |
107,453
+42,107
| +64% | +$32.8K |
|
|
PCM
5743
PCM Fund
PCM
$79.9M
| $83.2K | ﹤0.01% |
+10,807
| New | +$83.2K |
|
5744
Rackspace Technology
RXT
$347M
| $83K | ﹤0.01% |
37,540
-106,762
| -74% | -$236K |
|
5745
Xtant Medical Holdings
XTNT
$82.2M
| $81.8K | ﹤0.01% |
184,689
-112,467
| -38% | -$49.8K |
|
|
NIU
5746
Niu Technologies
NIU
$316M
| $80.5K | ﹤0.01% |
44,959
-8,381
| -16% | -$15K |
|
5747
AgEagle Aerial Systems
UAVS
$61.3M
| $80.4K | ﹤0.01% |
23,168
+21,049
| +993% | +$73K |
|
5748
Entera Bio
ENTX
$82.2M
| $80.3K | ﹤0.01% |
38,399
+17,741
| +86% | +$37.1K |
|
5749
Achieve Life Sciences
ACHV
$157M
| $79.3K | ﹤0.01% |
+22,534
| New | +$79.3K |
|
5750
Compass Therapeutics
CMPX
$613M
| $79.2K | ﹤0.01% |
54,615
+18,578
| +52% | +$26.9K |
|